SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (655)9/2/2001 1:47:05 PM
From: nigel bates  Read Replies (1) of 2243
 
Couple of public appearances -
Tom O'Brien (Sunesis Pharmaceuticals)
"Site-Directed Covalent Tethering Identifies Novel Enzyme Inhibitors"
grc.uri.edu

Jim Wells, Ph.D., Sunesis Corporation
"Binding and Ligand Discovery at Molecular Interfaces"
godot.urol.uic.edu

- but definitely quiet...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News